Skip to main content

Staging and Grouping of Retinoblastoma

  • Reference work entry
  • First Online:
Albert and Jakobiec's Principles and Practice of Ophthalmology
  • 67 Accesses

Abstract

The classification of most tumors results from an interaction between pathologists, oncologists, and the surgeon often aided by a tissue biopsy. Retinoblastoma is unique among childhood malignancies in that a direct biopsy is not done for diagnosis and currently classification is based on clinical features only. Additionally, for solid childhood malignancies, survival of the patient is generally the sole endpoint to measure therapeutic efficacy. However, in retinoblastoma, effective salvage of the globe is another critical and clinically relevant endpoint. For this reason group classifications for retinoblastoma are often tumor classifications; to be successful, they must reflect clinical reality and must be updated as the treatments change.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 5,499.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 6,499.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Reese AB, Ellsworth RM. The evaluation and current concept of retinoblastoma therapy. Trans Am Acad Ophthalmol Otolaryngol. 1963;67:164–72.

    CAS  PubMed  Google Scholar 

  2. Murphree AL. Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin N Am. 2005;18(1):41–53.

    Article  Google Scholar 

  3. Chantada G, Doz F, Antoneli CB, Grundy R, Clare Stannard FF, Dunkel IJ, et al. A proposal for an international retinoblastoma staging system. Pediatr Blood Cancer. 2006;47(6):801–5.

    Article  PubMed  Google Scholar 

  4. Murphree ALC, G.L. The staging and grouping of intraocular retinoblastoma. In: ADB S, Pe’er J, editors. Clinical ophthalmic oncology. Philadelphia: Elsevier; 2007. p. 422–7.

    Chapter  Google Scholar 

  5. Berman JJ. Tumor classification: molecular analysis meets Aristotle. BMC Cancer. 2004;4:10.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Fleming ID. Staging of pediatric cancers: problems in the development of a national system. Semin Surg Oncol. 1992;8(2):94–7.

    Article  CAS  PubMed  Google Scholar 

  7. Mallipatna A. AJCC cancer staging manual. 8th ed. Springer; 2017.

    Google Scholar 

  8. Berry JL, Jubran R, Wong K, Lee TC, Murphree AL, Kim JW. Factors predictive of long-term visual outcomes of Group D eyes treated with chemoreduction and low-dose IMRT salvage: the Children’s Hospital Los Angeles experience. Br J Ophthalmol. 2014;98(8):1061–5.

    Article  PubMed  Google Scholar 

  9. Kim JW, Aziz HA, McGovern K, Zolfaghari E, Jubran RF, Murphree AL, et al. Treatment outcomes of focal laser consolidation during chemoreduction for Group B retinoblastoma. Ophthalmol Retina. 2017;1(5):361–8.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Zhu D, Berry JL, Ediriwickrema L, Wong K, Lee TC, Murphree AL, et al. Long-term outcomes of Group B eyes in patients with retinoblastoma treated with short-course chemoreduction: experience from Children’s Hospital Los Angeles/University of Southern California. Ocul Oncol Pathol. 2015;2(2):105–11.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Berry JL, Jubran R, Kim JW, Wong K, Bababeygy SR, Almarzouki H, et al. Long-term outcomes of Group D eyes in bilateral retinoblastoma patients treated with chemoreduction and low-dose IMRT salvage. Pediatr Blood Cancer. 2013;60(4):688–93.

    Article  PubMed  Google Scholar 

  12. Shields CL, Mashayekhi A, Au AK, Czyz C, Leahey A, Meadows AT, et al. The international classification of retinoblastoma predicts chemoreduction success. Ophthalmology. 2006;113(12):2276–80.

    Article  PubMed  Google Scholar 

  13. Shields CL, Shields JA. Basic understanding of current classification and management of retinoblastoma. Curr Opin Ophthalmol. 2006;17(3):228–34.

    Article  PubMed  Google Scholar 

  14. Kim JW, Shah SN, Green S, O’Fee J, Tamrazi B, Berry JL. Tumor size criteria for Group D and E eyes in the International Classification System for Retinoblastoma: effects on rates of globe salvage and high-risk histopathologic features. Acta Ophthalmologica 2020; 98(1):e121–125.

    Google Scholar 

  15. Pratt CB, Fontanesi J, Lu X, Parham DM, Elfervig J, Meyer D. Proposal for a new staging scheme for intraocular and extraocular retinoblastoma based on an analysis of 103 globes. Oncologist. 1997;2(1):1–5.

    Article  CAS  PubMed  Google Scholar 

  16. Grabowski EF, Abramson DH. Intraocular and extraocular retinoblastoma. Hematol Oncol Clin North Am. 1987;1(4):721–35.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Section Editor information

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Berry, J.L. (2022). Staging and Grouping of Retinoblastoma. In: Albert, D.M., Miller, J.W., Azar, D.T., Young, L.H. (eds) Albert and Jakobiec's Principles and Practice of Ophthalmology. Springer, Cham. https://doi.org/10.1007/978-3-030-42634-7_267

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-42634-7_267

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-42633-0

  • Online ISBN: 978-3-030-42634-7

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics